Log in
NASDAQ:ANAB

AnaptysBio News Headlines

$16.08
+0.27 (+1.71 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$15.61
Now: $16.08
$16.18
50-Day Range
$14.44
MA: $16.93
$18.50
52-Week Range
$10.00
Now: $16.08
$43.10
Volume979,267 shs
Average Volume424,241 shs
Market Capitalization$439.05 million
P/E RatioN/A
Dividend YieldN/A
Beta0.72

Headlines

AnaptysBio (NASDAQ ANAB) News Headlines Today

Source:
DateHeadline
AnaptysBio (NASDAQ:ANAB) Rating Increased to Sell at BidaskClubAnaptysBio (NASDAQ:ANAB) Rating Increased to Sell at BidaskClub
marketbeat.com - September 17 at 3:18 AM
AnaptysBio (NASDAQ:ANAB) Rating Lowered to Strong Sell at BidaskClubAnaptysBio (NASDAQ:ANAB) Rating Lowered to Strong Sell at BidaskClub
marketbeat.com - August 13 at 3:13 AM
Acceleron Appoints Laura J. Hamill to its Board of Directors - StreetInsider.comAcceleron Appoints Laura J. Hamill to its Board of Directors - StreetInsider.com
streetinsider.com - September 17 at 8:47 AM
Acceleron Appoints Laura J. Hamill to its Board of Directors - Business WireAcceleron Appoints Laura J. Hamill to its Board of Directors - Business Wire
businesswire.com - September 16 at 3:06 PM
AnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference - GlobeNewswireAnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference - GlobeNewswire
globenewswire.com - September 11 at 5:22 PM
AnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare ConferenceAnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference
finance.yahoo.com - September 11 at 5:22 PM
ANAPTYSBIO ALERT: Bragar Eagel & Squire, PC is Investigating AnaptysBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswireANAPTYSBIO ALERT: Bragar Eagel & Squire, PC is Investigating AnaptysBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire
globenewswire.com - September 1 at 11:36 PM
ANAPTYSBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating AnaptysBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmANAPTYSBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating AnaptysBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - September 1 at 11:36 PM
 Brokerages Expect AnaptysBio Inc (NASDAQ:ANAB) Will Announce Earnings of -$0.76 Per Share Brokerages Expect AnaptysBio Inc (NASDAQ:ANAB) Will Announce Earnings of -$0.76 Per Share
americanbankingnews.com - September 1 at 4:32 PM
Shuman Glenn & Stecker Investigates AnaptysBio, Inc. - Business WireShuman Glenn & Stecker Investigates AnaptysBio, Inc. - Business Wire
businesswire.com - August 24 at 9:37 AM
Shuman Glenn & Stecker Investigates AnaptysBio, Inc.Shuman Glenn & Stecker Investigates AnaptysBio, Inc.
finance.yahoo.com - August 24 at 9:37 AM
How Should Investors Feel About AnaptysBios (NASDAQ:ANAB) CEO Remuneration?How Should Investors Feel About AnaptysBio's (NASDAQ:ANAB) CEO Remuneration?
finance.yahoo.com - August 21 at 1:34 PM
How Should Investors Feel About AnaptysBio's (NASDAQ:ANAB) CEO Remuneration?How Should Investors Feel About AnaptysBio's (NASDAQ:ANAB) CEO Remuneration?
finance.yahoo.com - August 21 at 1:34 PM
ANAB.OQ - AnaptysBio Inc Profile | ReutersANAB.OQ - AnaptysBio Inc Profile | Reuters
reuters.com - August 18 at 7:20 PM
Notable Monday Option Activity: ANAB, DDOG, ABMD - NasdaqNotable Monday Option Activity: ANAB, DDOG, ABMD - Nasdaq
nasdaq.com - August 17 at 6:16 PM
AnaptysBios lead drug fails to beat placebo in sinus inflammation studyAnaptysBio's lead drug fails to beat placebo in sinus inflammation study
seekingalpha.com - August 12 at 8:21 AM
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Lags Revenue Estimates - NasdaqAnaptysBio, Inc. (ANAB) Reports Q2 Loss, Lags Revenue Estimates - Nasdaq
nasdaq.com - August 10 at 1:16 PM
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Lags Revenue EstimatesAnaptysBio, Inc. (ANAB) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 1:16 PM
Anaptysbio (ANAB) Announces Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps - StreetInsider.comAnaptysbio (ANAB) Announces Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps - StreetInsider.com
streetinsider.com - August 10 at 8:15 AM
Form 8-K ANAPTYSBIO, INC For: Aug 10 - StreetInsider.comForm 8-K ANAPTYSBIO, INC For: Aug 10 - StreetInsider.com
streetinsider.com - August 10 at 8:15 AM
AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates - GlobeNewswireAnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates - GlobeNewswire
globenewswire.com - August 10 at 8:15 AM
AnaptysBio Reports Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal PolypsAnaptysBio Reports Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps
finance.yahoo.com - August 10 at 8:15 AM
AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline UpdatesAnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates
finance.yahoo.com - August 10 at 8:15 AM
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo FinanceAnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
finance.yahoo.com - August 6 at 10:34 PM
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - NasdaqAnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Nasdaq
nasdaq.com - August 6 at 5:31 PM
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseAnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 6 at 5:31 PM
AnaptysBio to Present at The 2020 Wedbush PacGrow Healthcare Conference - GlobeNewswireAnaptysBio to Present at The 2020 Wedbush PacGrow Healthcare Conference - GlobeNewswire
globenewswire.com - August 5 at 4:28 PM
AnaptysBio to Present at The 2020 Wedbush PacGrow Healthcare ConferenceAnaptysBio to Present at The 2020 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 5 at 4:28 PM
AnaptysBio Appoints Dr. Paul F. Lizzul As Chief Medical Officer - GlobeNewswireAnaptysBio Appoints Dr. Paul F. Lizzul As Chief Medical Officer - GlobeNewswire
www.globenewswire.com - July 31 at 11:33 AM
Did Hedge Funds Make The Right Call On AnaptysBio, Inc. (ANAB) ? - Yahoo FinanceDid Hedge Funds Make The Right Call On AnaptysBio, Inc. (ANAB) ? - Yahoo Finance
finance.yahoo.com - July 19 at 12:42 AM
AnaptysBio names new executives - Seeking AlphaAnaptysBio names new executives - Seeking Alpha
seekingalpha.com - July 15 at 2:37 PM
Form 8-K ANAPTYSBIO, INC For: Jul 13 - StreetInsider.comForm 8-K ANAPTYSBIO, INC For: Jul 13 - StreetInsider.com
www.streetinsider.com - July 15 at 9:36 AM
AnaptysBio Expands Executive Leadership Team Nasdaq:ANAB - GlobeNewswireAnaptysBio Expands Executive Leadership Team Nasdaq:ANAB - GlobeNewswire
www.globenewswire.com - July 15 at 9:36 AM
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio - Yahoo FinanceThe Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio - Yahoo Finance
finance.yahoo.com - July 9 at 8:15 PM
BRIEF-Anaptysbio Announces Orphan Drug Designation Of Imsidolimab For Treatment Of Generalized Pustular Psoriasis - ReutersBRIEF-Anaptysbio Announces Orphan Drug Designation Of Imsidolimab For Treatment Of Generalized Pustular Psoriasis - Reuters
www.reuters.com - July 8 at 10:43 PM
AnaptysBio Announces Orphan Drug Designation of Imsidolimab For Treatment of Generalized Pustular Psoriasis - GlobeNewswireAnaptysBio Announces Orphan Drug Designation of Imsidolimab For Treatment of Generalized Pustular Psoriasis - GlobeNewswire
www.globenewswire.com - July 8 at 5:42 PM
Companies Like AnaptysBio (NASDAQ:ANAB) Are In A Position To Invest In Growth - Yahoo FinanceCompanies Like AnaptysBio (NASDAQ:ANAB) Are In A Position To Invest In Growth - Yahoo Finance
finance.yahoo.com - July 7 at 2:58 PM
Companies Like AnaptysBio (NASDAQ:ANAB) Are In A Position To Invest In GrowthCompanies Like AnaptysBio (NASDAQ:ANAB) Are In A Position To Invest In Growth
finance.yahoo.com - July 7 at 2:58 PM
Is Myers Industries, Inc. (MYE) A Good Stock To Buy? - Yahoo FinanceIs Myers Industries, Inc. (MYE) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 30 at 2:50 PM
AnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock? - NasdaqAnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock? - Nasdaq
www.nasdaq.com - June 23 at 1:31 AM
AnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo FinanceAnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
finance.yahoo.com - June 22 at 3:30 PM
AnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock?AnaptysBio, Inc. (ANAB) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - June 22 at 3:30 PM
Hedge Funds Are Done Buying AnaptysBio, Inc. (ANAB) - Yahoo FinanceHedge Funds Are Done Buying AnaptysBio, Inc. (ANAB) - Yahoo Finance
finance.yahoo.com - June 15 at 9:19 AM
Hedge Funds Are Done Buying AnaptysBio, Inc. (ANAB)Hedge Funds Are Done Buying AnaptysBio, Inc. (ANAB)
finance.yahoo.com - June 15 at 9:19 AM
Iteris (ITI) Beats Q4 Earnings Estimates - NasdaqIteris (ITI) Beats Q4 Earnings Estimates - Nasdaq
www.nasdaq.com - June 10 at 1:11 PM
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - June 10 at 1:11 PM
Taiwan Semiconductor Secures Government Aid for U.S.-Based Chip Plant - NasdaqTaiwan Semiconductor Secures Government Aid for U.S.-Based Chip Plant - Nasdaq
www.nasdaq.com - June 9 at 8:24 PM
ESG ETFs to Gain as Goldman Sees Rising Popularity - NasdaqESG ETFs to Gain as Goldman Sees Rising Popularity - Nasdaq
www.nasdaq.com - June 9 at 8:24 PM
Heres Why Albemarle Gained 24.6% in May - NasdaqHere's Why Albemarle Gained 24.6% in May - Nasdaq
www.nasdaq.com - June 9 at 8:24 PM
Heres Why AnaptysBio Rose 22.1% in May - Motley FoolHere's Why AnaptysBio Rose 22.1% in May - Motley Fool
www.fool.com - June 9 at 8:24 PM
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo FinanceDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - May 27 at 11:49 PM
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo FinanceDEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo Finance
finance.yahoo.com - May 26 at 5:15 PM
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.